Skip to main content
Top
Published in:

01-11-2024 | Gynecologic Cancer | Research

Post-traumatic reactions and quality of life after pelvic exenteration for gynecologic cancer: a retrospective cohort study

Authors: Lora M. A. Thompson, Nele Loecher, Alexandra Albizu-Jacob, Hye Sook Chon, Robert M. Wenham, Kristine A. Donovan

Published in: Supportive Care in Cancer | Issue 11/2024

Login to get access

Abstract

Objective

We examined post-traumatic reactions and quality of life in women with recurrent gynecologic cancer who underwent a pelvic exenteration (PE), a potentially life-saving radical surgery associated with life-altering sequelae.

Methods

Twenty-one women who had completed PE at least 6 months prior completed the Impact of Event Scale-Revised, a measure of post-traumatic stress, the Post-Traumatic Growth Inventory, a measure of post-traumatic growth, the Center for Epidemiologic Studies-Depression Scale, and the European Organization for Research and Treatment of Cancer 30-item core Quality of Life Questionnaire. We examined the associations between these outcome variables, and quality of life scores were compared to normative values for the general and gynecologic cancer populations.

Results

Thirty percent of women reported clinically significant post-traumatic stress symptoms and 71% endorsed clinically significant depressive symptoms. More post-traumatic stress was associated with less post-traumatic growth, more depressive symptoms, and worse quality of life. In general, women’s quality of life was worse than the general population but comparable to women with stage III–IV ovarian cancer and women with cervical cancer. Social functioning was markedly lower in our sample and women reported more pain, diarrhea, and financial difficulties post-PE compared to published norms for the general population and women with ovarian or cervical cancer. There were no differences in quality of life based on age, type of PE, type of urinary diversion, or cancer type.

Conclusions

Findings support long-term continued symptom management and the ongoing rehabilitation of patients to optimize physical, psychological, and social well-being in PE survivorship.
Literature
1.
go back to reference Xu C, Garda AE, Kumar A (2023) R0 resection in recurrent gynecologic malignancy: pelvic exenteration and beyond. Curr Treat Options Oncol 24:262–273CrossRefPubMed Xu C, Garda AE, Kumar A (2023) R0 resection in recurrent gynecologic malignancy: pelvic exenteration and beyond. Curr Treat Options Oncol 24:262–273CrossRefPubMed
2.
3.
4.
go back to reference Lewandowska A, Szubert S, Koper K, Koper A, Cwynar G, Wicherek L (2020) Analysis of long-term outcomes in 44 patients following pelvic exenteration due to cervical cancer. World J Surg Oncol 18:1–9CrossRef Lewandowska A, Szubert S, Koper K, Koper A, Cwynar G, Wicherek L (2020) Analysis of long-term outcomes in 44 patients following pelvic exenteration due to cervical cancer. World J Surg Oncol 18:1–9CrossRef
5.
go back to reference Gheorghe M, Al Cozlea, Kiss SL et al (2021) Primary pelvic exenteration : our experience with 23 patients from a single institution. Exp Ther Med 22:1–6CrossRef Gheorghe M, Al Cozlea, Kiss SL et al (2021) Primary pelvic exenteration : our experience with 23 patients from a single institution. Exp Ther Med 22:1–6CrossRef
6.
go back to reference Ter Glane L, Hegele A, Wagner U, Boekhoff J (2021) Pelvic exenteration for recurrent or advanced gynecologic malignancies-analysis of outcome and complications. Gynecologic Oncol Rep 36:100757CrossRef Ter Glane L, Hegele A, Wagner U, Boekhoff J (2021) Pelvic exenteration for recurrent or advanced gynecologic malignancies-analysis of outcome and complications. Gynecologic Oncol Rep 36:100757CrossRef
7.
go back to reference Bouraoui I, Bouaziz H, Tounsi N et al (2022) Survival after pelvic exenteration for cervical cancer. J Obstet Gynaecol India 72:66–71CrossRefPubMed Bouraoui I, Bouaziz H, Tounsi N et al (2022) Survival after pelvic exenteration for cervical cancer. J Obstet Gynaecol India 72:66–71CrossRefPubMed
8.
go back to reference Ter Glane L, Hegele A, Wagner U, Boekhoff J (2022) Gynecologic oncology: pelvic exenteration for advanced recurring cervical cancers-a single center analysis. Cancer Diagnosis Prognosis 2:308CrossRefPubMedPubMedCentral Ter Glane L, Hegele A, Wagner U, Boekhoff J (2022) Gynecologic oncology: pelvic exenteration for advanced recurring cervical cancers-a single center analysis. Cancer Diagnosis Prognosis 2:308CrossRefPubMedPubMedCentral
9.
go back to reference Stanca M, Căpîlna DM, Căpîlna ME (2022) Long-term survival, prognostic factors, and quality of life of patients undergoing pelvic exenteration for cervical cancer. Cancers 14:2346CrossRefPubMedPubMedCentral Stanca M, Căpîlna DM, Căpîlna ME (2022) Long-term survival, prognostic factors, and quality of life of patients undergoing pelvic exenteration for cervical cancer. Cancers 14:2346CrossRefPubMedPubMedCentral
10.
go back to reference Sabiani L, Knight S, Blache G et al (2022) Operative prognostic scores for pelvic exenterations for gynecological cancer: when should we operate. J Surg Res 5:449–455CrossRef Sabiani L, Knight S, Blache G et al (2022) Operative prognostic scores for pelvic exenterations for gynecological cancer: when should we operate. J Surg Res 5:449–455CrossRef
11.
go back to reference Haidopoulos D, Pergialiotis V, Aggelou K et al (2022) Pelvic exenteration for gynecologic malignancies: the experience of a tertiary center from Greece. Surg Oncol 40:101702CrossRefPubMed Haidopoulos D, Pergialiotis V, Aggelou K et al (2022) Pelvic exenteration for gynecologic malignancies: the experience of a tertiary center from Greece. Surg Oncol 40:101702CrossRefPubMed
12.
go back to reference Loverro M, Aloisi A, Tortorella L, Aletti GD, Kumar A (2024) Trends and current aspects of reconstructive surgery for gynecological cancers. Int J Gynecol Cancer 34:426–435CrossRefPubMed Loverro M, Aloisi A, Tortorella L, Aletti GD, Kumar A (2024) Trends and current aspects of reconstructive surgery for gynecological cancers. Int J Gynecol Cancer 34:426–435CrossRefPubMed
13.
go back to reference Moolenaar LR, van Rangelrooij LE, van Poelgeest MIE et al (2023) Clinical outcomes of pelvic exenteration for gynecologic malignancies. Gynecol Oncol 171:114–120CrossRefPubMed Moolenaar LR, van Rangelrooij LE, van Poelgeest MIE et al (2023) Clinical outcomes of pelvic exenteration for gynecologic malignancies. Gynecol Oncol 171:114–120CrossRefPubMed
14.
go back to reference Tortorella L, Marco C, Loverro M et al (2024) Predictive factors of surgical complications after pelvic exenteration for gynecological malignancies: a large single-institution experience. J Gynecol Oncol 35:e4-e−19CrossRefPubMed Tortorella L, Marco C, Loverro M et al (2024) Predictive factors of surgical complications after pelvic exenteration for gynecological malignancies: a large single-institution experience. J Gynecol Oncol 35:e4-e−19CrossRefPubMed
15.
go back to reference Nelson AM, Albizu-Jacob A, Fenech AL, Chon HS, Wenham RM, Donovan KD (2018) Quality of life after pelvic exenteration for gynecologic cancer: findings from a qualitative study. Psychooncology 27:2357–2362CrossRefPubMed Nelson AM, Albizu-Jacob A, Fenech AL, Chon HS, Wenham RM, Donovan KD (2018) Quality of life after pelvic exenteration for gynecologic cancer: findings from a qualitative study. Psychooncology 27:2357–2362CrossRefPubMed
16.
go back to reference Swartzman S, Booth JN, Munro A, Sani F (2017) Posttraumatic stress disorder after cancer diagnosis in adults: a meta-analysis. Depress Anxiety 34:327–339CrossRefPubMed Swartzman S, Booth JN, Munro A, Sani F (2017) Posttraumatic stress disorder after cancer diagnosis in adults: a meta-analysis. Depress Anxiety 34:327–339CrossRefPubMed
17.
go back to reference Lemogne C (2019) Post-traumatic stress disorder and comorbid physical conditions. J Psychosom Res 126:109818CrossRefPubMed Lemogne C (2019) Post-traumatic stress disorder and comorbid physical conditions. J Psychosom Res 126:109818CrossRefPubMed
18.
go back to reference Tedeschi RG, Calhoun LG (2004) Posttraumatic growth: conceptual foundations and empirical evidence. Psychol Inq 15:1–18CrossRef Tedeschi RG, Calhoun LG (2004) Posttraumatic growth: conceptual foundations and empirical evidence. Psychol Inq 15:1–18CrossRef
19.
go back to reference Seiler A, Jenewein J (2019) Resilience in cancer patients. Front Psych 10:208CrossRef Seiler A, Jenewein J (2019) Resilience in cancer patients. Front Psych 10:208CrossRef
20.
go back to reference Casellas-Grau A, Ochoa C, Ruini C (2017) Psychological and clinical correlates of posttraumatic growth in cancer: a systematic and critical review. Psychooncology 26:2007–2018CrossRefPubMed Casellas-Grau A, Ochoa C, Ruini C (2017) Psychological and clinical correlates of posttraumatic growth in cancer: a systematic and critical review. Psychooncology 26:2007–2018CrossRefPubMed
21.
go back to reference Liu Z, Doege D, Thong MSY, Arndt V (2020) The relationship between posttraumatic growth and health-related quality of life in adult cancer survivors: a systematic review. J Affect Disord 276:159–168CrossRefPubMed Liu Z, Doege D, Thong MSY, Arndt V (2020) The relationship between posttraumatic growth and health-related quality of life in adult cancer survivors: a systematic review. J Affect Disord 276:159–168CrossRefPubMed
22.
go back to reference Marziliano A, Tuman M, Moyer A (2020) The relationship between post-traumatic stress and post-traumatic growth in cancer patients and survivors: a systematic review and meta-analysis. Psychooncology 29:604–616CrossRefPubMed Marziliano A, Tuman M, Moyer A (2020) The relationship between post-traumatic stress and post-traumatic growth in cancer patients and survivors: a systematic review and meta-analysis. Psychooncology 29:604–616CrossRefPubMed
23.
go back to reference Posluszny DM, Baum A, Edwards RP, Dew MA (2011) Posttraumatic growth in women one year after diagnosis for gynecologic cancer or benign conditions. J Psychosoc Oncol 29:560–572CrossRef Posluszny DM, Baum A, Edwards RP, Dew MA (2011) Posttraumatic growth in women one year after diagnosis for gynecologic cancer or benign conditions. J Psychosoc Oncol 29:560–572CrossRef
24.
go back to reference Shand LK, Brooker JE, Burney S, Fletcher J, Ricciardelli LA (2018) Psychosocial factors associated with posttraumatic stress and growth in Australian women with ovarian cancer. J Psychosoc Oncol 36:470–483CrossRefPubMed Shand LK, Brooker JE, Burney S, Fletcher J, Ricciardelli LA (2018) Psychosocial factors associated with posttraumatic stress and growth in Australian women with ovarian cancer. J Psychosoc Oncol 36:470–483CrossRefPubMed
25.
go back to reference Harji DP, Griffiths B, Velikova G, Sagar PM, Brown J (2016) Systematic review of health-related quality of life in patients undergoing pelvic exenteration. Eur J Surg Oncol 42:1132–1145CrossRefPubMed Harji DP, Griffiths B, Velikova G, Sagar PM, Brown J (2016) Systematic review of health-related quality of life in patients undergoing pelvic exenteration. Eur J Surg Oncol 42:1132–1145CrossRefPubMed
26.
go back to reference Collaborative P (2019) Pelvic exenteration for advanced nonrectal pelvic malignancy. Ann Surg 270:899–905 Collaborative P (2019) Pelvic exenteration for advanced nonrectal pelvic malignancy. Ann Surg 270:899–905
27.
go back to reference Horowitz M, Wilner N, Alvarez W (1979) Impact of event scale: a measure of subjective stress. Psychosom Med 41:209–218CrossRefPubMed Horowitz M, Wilner N, Alvarez W (1979) Impact of event scale: a measure of subjective stress. Psychosom Med 41:209–218CrossRefPubMed
28.
go back to reference Weiss D, Marmar C (1997) The impact of event scale-revised. In: Wilson JKT (ed) Assessing psychological trauma and post-traumatic stress disorder. Guilford Press, New York, NY, pp 399–411 Weiss D, Marmar C (1997) The impact of event scale-revised. In: Wilson JKT (ed) Assessing psychological trauma and post-traumatic stress disorder. Guilford Press, New York, NY, pp 399–411
29.
go back to reference Tedeschi RG, Calhoun LG (1996) The posttraumatic growth inventory: measuring the positive legacy of trauma. J Trauma Stress 9:455–471CrossRefPubMed Tedeschi RG, Calhoun LG (1996) The posttraumatic growth inventory: measuring the positive legacy of trauma. J Trauma Stress 9:455–471CrossRefPubMed
30.
go back to reference Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef
31.
go back to reference Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed
32.
go back to reference Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group (2001) The EORTC QLQ-C30 Scoring Manual, 3rd edn. European Organisation for Research and Treatment of Cancer, Brussels Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group (2001) The EORTC QLQ-C30 Scoring Manual, 3rd edn. European Organisation for Research and Treatment of Cancer, Brussels
33.
go back to reference Nolte S, Liegl G, Petersen MA et al (2019) General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the United States. Eur J Cancer 107:153–163CrossRefPubMed Nolte S, Liegl G, Petersen MA et al (2019) General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the United States. Eur J Cancer 107:153–163CrossRefPubMed
34.
go back to reference Scott NW, Fayers PM, Aaronson NK et al (2008) EORTC QLQ-C30 reference values. European Organisation for Research and Treatment of Cancer, Brussels Scott NW, Fayers PM, Aaronson NK et al (2008) EORTC QLQ-C30 reference values. European Organisation for Research and Treatment of Cancer, Brussels
35.
go back to reference Osoba D, Roderigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality of life. J Clin Oncol 16:139–144CrossRefPubMed Osoba D, Roderigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality of life. J Clin Oncol 16:139–144CrossRefPubMed
36.
go back to reference Rezk YA, Hurley KE, Carter J et al (2013) A prospective study of quality of life in patients undergoing pelvic exenteration: interim results. Gynecol Oncol 128:191–197CrossRefPubMed Rezk YA, Hurley KE, Carter J et al (2013) A prospective study of quality of life in patients undergoing pelvic exenteration: interim results. Gynecol Oncol 128:191–197CrossRefPubMed
37.
go back to reference PelvExCollaborative (2019) Pelvic exenteration for advanced nonrectal pelvic malignancy. Annals Surg 270:899–905 PelvExCollaborative (2019) Pelvic exenteration for advanced nonrectal pelvic malignancy. Annals Surg 270:899–905
38.
go back to reference Shand LK, Brooker JE, Burney S, Fletcher J, Ricciardelli LA (2015) Symptoms of posttraumatic stress in Australian women with ovarian cancer. Psychooncology 24:190–196CrossRefPubMed Shand LK, Brooker JE, Burney S, Fletcher J, Ricciardelli LA (2015) Symptoms of posttraumatic stress in Australian women with ovarian cancer. Psychooncology 24:190–196CrossRefPubMed
39.
go back to reference Tung H-Y, Lin Y-H, Kao C-C, Wu S-F (2018) The relationship among symptom distress, posttraumatic stress symptoms, and depression in women with female-specific cancers. Cancer Nurs 41:181–188CrossRefPubMed Tung H-Y, Lin Y-H, Kao C-C, Wu S-F (2018) The relationship among symptom distress, posttraumatic stress symptoms, and depression in women with female-specific cancers. Cancer Nurs 41:181–188CrossRefPubMed
40.
go back to reference Shand LK, Cowlishaw S, Brooker JE, Burney S, Ricciardelli LA (2015) Correlates of post-traumatic stress symptoms and growth in cancer patients: a systematic review and meta-analysis. Psychooncology 24:624–634CrossRefPubMed Shand LK, Cowlishaw S, Brooker JE, Burney S, Ricciardelli LA (2015) Correlates of post-traumatic stress symptoms and growth in cancer patients: a systematic review and meta-analysis. Psychooncology 24:624–634CrossRefPubMed
41.
go back to reference Harji DP, Williams A, McKigney N et al (2022) Utilising quality of life outcome trajectories to aid patient decision making in pelvic exenteration. Eur J Surg Oncol 48:2238–2249CrossRefPubMed Harji DP, Williams A, McKigney N et al (2022) Utilising quality of life outcome trajectories to aid patient decision making in pelvic exenteration. Eur J Surg Oncol 48:2238–2249CrossRefPubMed
Metadata
Title
Post-traumatic reactions and quality of life after pelvic exenteration for gynecologic cancer: a retrospective cohort study
Authors
Lora M. A. Thompson
Nele Loecher
Alexandra Albizu-Jacob
Hye Sook Chon
Robert M. Wenham
Kristine A. Donovan
Publication date
01-11-2024
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 11/2024
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-024-08899-0

Other articles of this Issue 11/2024

Supportive Care in Cancer 11/2024 Go to the issue
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

  • Webinar | 01-10-2024 | 12:30 (CEST)

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Get a reminder for the on-demand version